IBDEI2L0 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43304,1,3,0)
 ;;=3^Family Hx of Malig Neop Breast
 ;;^UTILITY(U,$J,358.3,43304,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,43304,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,43305,0)
 ;;=Z80.41^^197^2185^27
 ;;^UTILITY(U,$J,358.3,43305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43305,1,3,0)
 ;;=3^Family Hx of Malig Neop Ovary
 ;;^UTILITY(U,$J,358.3,43305,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,43305,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,43306,0)
 ;;=Z80.42^^197^2185^28
 ;;^UTILITY(U,$J,358.3,43306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43306,1,3,0)
 ;;=3^Family Hx of Malig Neop Prostate
 ;;^UTILITY(U,$J,358.3,43306,1,4,0)
 ;;=4^Z80.42
 ;;^UTILITY(U,$J,358.3,43306,2)
 ;;=^5063349
 ;;^UTILITY(U,$J,358.3,43307,0)
 ;;=Z80.43^^197^2185^29
 ;;^UTILITY(U,$J,358.3,43307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43307,1,3,0)
 ;;=3^Family Hx of Malig Neop Testis
 ;;^UTILITY(U,$J,358.3,43307,1,4,0)
 ;;=4^Z80.43
 ;;^UTILITY(U,$J,358.3,43307,2)
 ;;=^5063350
 ;;^UTILITY(U,$J,358.3,43308,0)
 ;;=Z80.6^^197^2185^20
 ;;^UTILITY(U,$J,358.3,43308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43308,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,43308,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,43308,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,43309,0)
 ;;=Z80.8^^197^2185^32
 ;;^UTILITY(U,$J,358.3,43309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43309,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,43309,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,43309,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,43310,0)
 ;;=Z81.8^^197^2185^34
 ;;^UTILITY(U,$J,358.3,43310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43310,1,3,0)
 ;;=3^Family Hx of Mental & Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,43310,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,43310,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,43311,0)
 ;;=Z82.3^^197^2185^41
 ;;^UTILITY(U,$J,358.3,43311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43311,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,43311,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,43311,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,43312,0)
 ;;=Z83.2^^197^2185^3
 ;;^UTILITY(U,$J,358.3,43312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43312,1,3,0)
 ;;=3^Family Hx of Blood/Blood-Forming Organ Diseases
 ;;^UTILITY(U,$J,358.3,43312,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,43312,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,43313,0)
 ;;=Z82.49^^197^2185^18
 ;;^UTILITY(U,$J,358.3,43313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43313,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease
 ;;^UTILITY(U,$J,358.3,43313,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,43313,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,43314,0)
 ;;=Z82.5^^197^2185^2
 ;;^UTILITY(U,$J,358.3,43314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43314,1,3,0)
 ;;=3^Family Hx of Asthma
 ;;^UTILITY(U,$J,358.3,43314,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,43314,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,43315,0)
 ;;=Z82.61^^197^2185^1
 ;;^UTILITY(U,$J,358.3,43315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43315,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,43315,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,43315,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,43316,0)
 ;;=Z82.69^^197^2185^36
 ;;^UTILITY(U,$J,358.3,43316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43316,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System Diseases
 ;;^UTILITY(U,$J,358.3,43316,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,43316,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,43317,0)
 ;;=Z83.3^^197^2185^7
